The list of awardees for the 2021 ChinaVenture Awards was official released on May 30, 2022. 

Huaxing Growth Capital, China Renaissance's principal private equity investment and management arm, was honored to win the following award categories:    

·「China's Top 20 Private Equity Investment Institutions in 2021」    

·「China's Top 20 Foreign-Funded Private Equity Investment Institutions in 2021」    

China Renaissance's Investment Banking segment has been honored for 15 consecutive years:    

·「China's Top 1 Best New Investment Bank in 2021」    

What's worth mentioning is that many of Huaxing Growth Capital's portfolio companies were also included in the list of awardees. These awards represent the market's vote of confidence in CR's investment capabilities and brand influence. We look forward to continuing to execute our proven business strategy to achieve more positive outcomes in the future!

Founded in 2005, China Renaissance is a leading financial institution that provides a full range of trusted services, including investment management, private placement, M&A advisory, equity underwriting, sales & trading, research and wealth management, among others.    

Huaxing Growth Capital ("HGC") was launched in 2013 by China Renaissance as the Company's principal private equity investment and management arm. As of December 31, 2021, CR's private equity funds recorded approximately RMB49 billion in assets under management ("AUM"), with HGC's AUM reaching RMB36.8 billion. CR's private equity funds have been focused on investing into smart industries, smart technologies, smart healthcare, smart consumerism and smart enterprises. To date, HGC has successfully invested in a number of listed companies, including Meituan, KE, WuXi AppTec, Bilibili, Li Auto, Pop Mart, MGI, SenseTime, Navitas and AInnovation, as well as top industry players in other sectors, such as SVOLT, Dreame, Calterah and Hua Kong Tsingjiao, among others.    

Since China Renaissance's inception in 2005, the Company's Investment Banking segment has continued to be a core part of its business and maintained its leading position in the private placement market for 17 consecutive years by advising leading companies across smart technologies, smart healthcare, smart enterprises and other high-growth sectors.    

-End-